447 related articles for article (PubMed ID: 30635355)
21. Suppressive IL-17A
Downs-Canner S; Berkey S; Delgoffe GM; Edwards RP; Curiel T; Odunsi K; Bartlett DL; Obermajer N
Nat Commun; 2017 Mar; 8():14649. PubMed ID: 28290453
[TBL] [Abstract][Full Text] [Related]
22. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
Coutinho A; Caramalho I; Seixas E; Demengeot J
Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
[TBL] [Abstract][Full Text] [Related]
23. Anti-GITR Antibody Treatment Increases TCR Repertoire Diversity of Regulatory but not Effector T Cells Engaged in the Immune Response Against B16 Melanoma.
Scirka B; Szurek E; Pietrzak M; Rempala G; Kisielow P; Ignatowicz L; Miazek A
Arch Immunol Ther Exp (Warsz); 2017 Dec; 65(6):553-564. PubMed ID: 28638937
[TBL] [Abstract][Full Text] [Related]
24. Conventional and Regulatory CD4+ T Cells That Share Identical TCRs Are Derived from Common Clones.
Wolf KJ; Emerson RO; Pingel J; Buller RM; DiPaolo RJ
PLoS One; 2016; 11(4):e0153705. PubMed ID: 27100298
[TBL] [Abstract][Full Text] [Related]
25. Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers.
Zhang H; Liu L; Zhang J; Chen J; Ye J; Shukla S; Qiao J; Zhan X; Chen H; Wu CJ; Fu YX; Li B
Clin Cancer Res; 2020 Mar; 26(6):1359-1371. PubMed ID: 31831563
[TBL] [Abstract][Full Text] [Related]
26. Suppression of inducible CD4 regulatory cells by MHC class I-restricted human tumor epitope specific TCR engineered multifunctional CD4 T cells.
Chhabra A; Mukherji B
Hum Immunol; 2016 Oct; 77(10):905-911. PubMed ID: 27320826
[TBL] [Abstract][Full Text] [Related]
27. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner.
Yuan XL; Chen L; Li MX; Dong P; Xue J; Wang J; Zhang TT; Wang XA; Zhang FM; Ge HL; Shen LS; Xu D
Clin Immunol; 2010 Mar; 134(3):277-88. PubMed ID: 19900843
[TBL] [Abstract][Full Text] [Related]
28. CD4+ T effectors specific for the tumor antigen NY-ESO-1 are highly enriched at ovarian cancer sites and coexist with, but are distinct from, tumor-associated Treg.
Ayyoub M; Pignon P; Classe JM; Odunsi K; Valmori D
Cancer Immunol Res; 2013 Nov; 1(5):303-8. PubMed ID: 24777968
[TBL] [Abstract][Full Text] [Related]
29. Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.
Parkhurst M; Gros A; Pasetto A; Prickett T; Crystal JS; Robbins P; Rosenberg SA
Clin Cancer Res; 2017 May; 23(10):2491-2505. PubMed ID: 27827318
[No Abstract] [Full Text] [Related]
30. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B
Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
[TBL] [Abstract][Full Text] [Related]
31. Thymic and peripheral differentiation of regulatory T cells.
Lee HM; Bautista JL; Hsieh CS
Adv Immunol; 2011; 112():25-71. PubMed ID: 22118406
[TBL] [Abstract][Full Text] [Related]
32. Helios
Thornton AM; Lu J; Korty PE; Kim YC; Martens C; Sun PD; Shevach EM
Eur J Immunol; 2019 Mar; 49(3):398-412. PubMed ID: 30620397
[TBL] [Abstract][Full Text] [Related]
33. Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing.
Lu YC; Zheng Z; Lowery FJ; Gartner JJ; Prickett TD; Robbins PF; Rosenberg SA
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34321276
[TBL] [Abstract][Full Text] [Related]
34. Human CD45RA(-) FoxP3(hi) Memory-Type Regulatory T Cells Show Distinct TCR Repertoires With Conventional T Cells and Play an Important Role in Controlling Early Immune Activation.
Lei H; Kuchenbecker L; Streitz M; Sawitzki B; Vogt K; Landwehr-Kenzel S; Millward J; Juelke K; Babel N; Neumann A; Reinke P; Volk HD
Am J Transplant; 2015 Oct; 15(10):2625-35. PubMed ID: 25988290
[TBL] [Abstract][Full Text] [Related]
35. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
Klages K; Mayer CT; Lahl K; Loddenkemper C; Teng MW; Ngiow SF; Smyth MJ; Hamann A; Huehn J; Sparwasser T
Cancer Res; 2010 Oct; 70(20):7788-99. PubMed ID: 20924102
[TBL] [Abstract][Full Text] [Related]
36. Comparison of circulating and intratumoral regulatory T cells in patients with renal cell carcinoma.
Asma G; Amal G; Raja M; Amine D; Mohammed C; Amel BA
Tumour Biol; 2015 May; 36(5):3727-34. PubMed ID: 25563193
[TBL] [Abstract][Full Text] [Related]
37. Granzyme B-expressing treg cells are enriched in colorectal cancer and present the potential to eliminate autologous T conventional cells.
Sun B; Liu M; Cui M; Li T
Immunol Lett; 2020 Jan; 217():7-14. PubMed ID: 31669380
[TBL] [Abstract][Full Text] [Related]
38. Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients.
Xydia M; Rahbari R; Ruggiero E; Macaulay I; Tarabichi M; Lohmayer R; Wilkening S; Michels T; Brown D; Vanuytven S; Mastitskaya S; Laidlaw S; Grabe N; Pritsch M; Fronza R; Hexel K; Schmitt S; Müller-Steinhardt M; Halama N; Domschke C; Schmidt M; von Kalle C; Schütz F; Voet T; Beckhove P
Nat Commun; 2021 Feb; 12(1):1119. PubMed ID: 33602930
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D
J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma.
Wei S; Kryczek I; Edwards RP; Zou L; Szeliga W; Banerjee M; Cost M; Cheng P; Chang A; Redman B; Herberman RB; Zou W
Cancer Res; 2007 Aug; 67(15):7487-94. PubMed ID: 17671219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
